Advancing Pharmaceutical Standards with High-Quality Impurity Reference Materials

ASTORIA, N.Y. - July 16, 2025 - PRLog -- In the evolving landscape of pharmaceutical R&D and regulatory compliance, access to high-quality impurity reference standards is non-negotiable. Impurity profiling is critical for ensuring the safety, efficacy, and quality of drug substances and products. Whether you are working in drug discovery, formulation, or quality control, having reliable impurity reference materials helps meet global pharmacopoeial and ICH guidelines.

Let's explore the significance of key impurity categories across various drug molecules, each playing a vital role in analytical method development and regulatory submission.

Macimorelin Acetate: Supporting Endocrine Drug Development
Macimorelin Acetate, used primarily for diagnosing adult growth hormone deficiency, demands accurate impurity profiling due to its sensitive nature and role in endocrine diagnostics. Laboratories rely on high-purity Macimorelin Acetate impurity standards for method validation, stability studies, and regulatory filings.

With increased use of growth hormone secretagogues in clinical settings, having access to traceable and well-characterized Macimorelin impurity standards has become crucial for both generic and innovator companies.
https://aquigenbio.com/products/impurity-standards/halobe...

Halobetasol & Diflorasone: Corticosteroid Impurity Profiling
Topical corticosteroids like Halobetasol and Diflorasone are widely used for treating inflammatory skin conditions. However, due to their potency and potential for side effects, impurity control is vital for safe formulation.

Key impurities include:

9a-Chloro-9-desfluoro Halobetasol 17-Propionate
https://aquigenbio.com/product/diflorasone-21-propionate/
Diflorasone 17-propionate
Diflorasone 17-propionate-21-mesylate
Diflorasone 21-Propionate
These impurities are used in identification, qualification, and quantification procedures, particularly when working under stringent regulatory environments like the USFDA or EMA. Availability of these reference materials supports routine quality control and helps pharmaceutical manufacturers maintain compliance and patient safety.